Incidence of Ischemic strokes in the Minimally Invasive Surgery plus rt-PA for Intracerebral Hemorrhage Evacuation (MISTIE II) Phase II Clinical Trial (P3.100)

Conclusions The incidence of ischemic strokes in the MISTIE II trial was low suggesting that the procedure was not likely a contributing factor. Mass effect, initial blood pressure elevation and significant decrease in blood pressure in the acute phase may be predisposing factors.Disclosure: Dr. Rivera Lara has nothing to disclose. Dr. Nekoovaght-Tak has nothing to disclose. Dr. Dlugash has nothing to disclose. Dr. McBee has nothing to disclose. Dr. Zuccarello has nothing to disclose. Dr. Hanley has received research support from the FDA, Cathflo, and Genentech. Dr. Ziai has received personal compensation in an editorial capacity for Oakstone Medical Publishing.

Source: Neurology - April 8, 2015 Category: Neurology Authors: Rivera Lara, L., Nekoovaght-Tak, S., Dlugash, R., McBee, N., Zuccarello, M., Hanley, D., Ziai, W. Tags: Cerebrovascular Disease and Interventional Neurology: Intracerebral Hemorrhage Source Type: research